PACB
Pacific Biosciences of California Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.160
Kõrge
$1.160
Madal
$1.160
Maht
8.25M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date
Target ALS, a nonprofit breaking down barriers to amyotrophic lateral sclerosis (ALS) research, has partnered with PacBio (Nasdaq: PACB), a leading...
PacBio to Present at Upcoming Investor Conferences
MENLO PARK, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the
PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene
MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally recognized
Piper Sandler Maintains Neutral on Pacific Biosciences, Lowers Price Target to $1.25
Piper Sandler analyst David Westenberg maintains Pacific Biosciences with a Neutral and lowers the price target from $2 to $1.25.
Stephens & Co. Reiterates Overweight on Pacific Biosciences, Maintains $1.8 Price Target
Stephens & Co. analyst Mason Carrico reiterates Pacific Biosciences with a Overweight and maintains $1.8 price target.
Seotud aktsiad
VRME
VerifyMe Inc.
HTIBP
Healthcare Trust Inc. 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock
RWTN
Redwood Trust Inc. 9.125% Senior Notes Due 2029
AI
C3.ai Inc.
NFLX
Netflix Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.